ArticleCureus2026
Collagenofibrotic Glomerulopathy With Concurrent Ostium Secundum Atrial Septal Defect and Anti-Ku Antibody Positivity: A Rare Case.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Collagenofibrotic glomerulopathy (CG) is an exceptionally rare idiopathic glomerular disease defined by pathological intraglomerular accumulation of type III collagen fibrils within the mesangial matrix and subendothelial space. We report the case of a 35-year-old woman presenting with generalized anasarca, frothy urine, and exertional dyspnea. Laboratory investigations revealed nephrotic syndrome with a 24-hour urinary protein of 3,658 mg/day, serum albumin of 2 g/dL, and progressive renal dysfunction with serum creatinine rising from 3.13 to 5.25 mg/dL. Echocardiography incidentally demonstrated an ostium secundum atrial septal defect with mild pulmonary arterial hypertension, while serology showed a strongly positive anti-Ku antibody (3+). Renal biopsy also showed diffuse mesangial expansion by Congo red-negative eosinophilic material with marked narrowing and focal obliteration of capillary lumina. Immunofluorescence studies demonstrated weak mesangial staining for both kappa and lambda light chains. Immunohistochemistry confirmed faint positive staining for type III collagen in mesangial regions, confirming the diagnosis of CG. Treatment consisted of diuretics, antihypertensive therapy, corticosteroids, and supportive measures. Despite these interventions, renal function continued to deteriorate, with estimated glomerular filtration rate decreasing from 19 to 10 mL/minute/1.73 m² at discharge. The present case highlights the utility of immunohistochemistry in establishing the diagnosis of CG when electron microscopy is unavailable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.